Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Issue 5 (16th April 2021) - Ziff, Monica; Lawson, Gabrielle; De-Silva, Dunnya; Cheesman, Simon; Kyriakou, Charalampia; Mahmood, Shameem; Papanikolaou, Xenofon; Rabin, Neil; Sachchithananthan, Sajitha; Sive, Jonathan; Wechalekar, Ashutosh; Yong, Kwee; et al.